Successful characterization of degradation products of drugs using LC-MS tools: Application to piroxicam and meloxicam
暂无分享,去创建一个
[1] Ravi P. Shah,et al. Strategy for identification and characterization of small quantities of drug degradation products using LC and LC-MS: application to valsartan, a model drug. , 2010, Drug testing and analysis.
[2] M. Starek,et al. A review of analytical techniques for determination of oxicams, nimesulide and nabumetone. , 2009, Talanta.
[3] N. Desai,et al. Stability Indicating HPTLC Determination of Meloxicam , 2008, Indian journal of pharmaceutical sciences.
[4] S. Meena,et al. An overview of the recent developments in analytical methodologies for determination of COX-2 inhibitors in bulk drugs, pharmaceuticals and biological matrices. , 2005, Journal of pharmaceutical and biomedical analysis.
[5] R. Bhardwaj,et al. Development and validation of a new high-performance liquid chromatographic estimation method of meloxicam in biological samples. , 2000, Journal of chromatography. B, Biomedical sciences and applications.
[6] H. Kopelent-Frank,et al. Stability indicating assays for the determination of piroxicam--comparison of methods. , 1999, Journal of pharmaceutical and biomedical analysis.
[7] Saranjit Singh,et al. Guidance on Conduct of Stress Tests to Determine Inherent Stability of Drugs , 2000 .
[8] J. Vane,et al. Mechanism of action of antiinflammatory drugs. , 1998, International journal of tissue reactions.
[9] B. Brown. The mechanism of thermal decarboxylation , 1951 .